Morgan R, Hecht F
Cancer Genet Cytogenet. 1985 Nov;18(3):243-9. doi: 10.1016/0165-4608(85)90089-5.
Chromosome abnormalities were analyzed in 200 consecutive patients with preleukemia and leukemia, and four patients were found with a deletion of 13q14 for an incidence of 2%. Together with data on chromosome aberrations in cancer from the literature, our results indicate clearly that deletion of band 13q14 is a nonrandom chromosome anomaly in premalignant and malignant blood disorders. Deletion of 13q14 appears specifically to constitute a primary event in the initiation of preleukemia. An additional rearrangement involving another chromosome must occur for progression of the preleukemia to acute nonlymphocytic leukemia.
对200例白血病前期和白血病患者的染色体异常进行了分析,发现4例患者存在13q14缺失,发生率为2%。结合文献中关于癌症染色体畸变的数据,我们的结果清楚地表明,13q14带的缺失是恶性前期和恶性血液疾病中一种非随机的染色体异常。13q14缺失似乎特别构成了白血病前期起始的一个主要事件。白血病前期进展为急性非淋巴细胞白血病必须发生涉及另一条染色体的额外重排。